Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $682.60 | 34 | 87.5% |
| Education | $97.89 | 6 | 12.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $282.42 | 12 | $0 (2017) |
| Boston Scientific Corporation | $92.36 | 2 | $0 (2022) |
| ABBVIE INC. | $81.68 | 5 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $67.55 | 5 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $54.13 | 2 | $0 (2017) |
| Coloplast Corp | $52.02 | 4 | $0 (2018) |
| PFIZER INC. | $43.89 | 3 | $0 (2018) |
| Rochester Medical Corporation | $40.88 | 2 | $0 (2017) |
| 180 Medical, Inc. | $14.70 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $13.86 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $67.30 | 4 | ABBVIE INC. ($54.00) |
| 2018 | $150.86 | 6 | BOSTON SCIENTIFIC CORPORATION ($79.06) |
| 2017 | $562.33 | 30 | Astellas Pharma US Inc ($282.42) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/29/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $20.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $20.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/18/2022 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: LithoVue_URO | ||||||
| 12/07/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $79.06 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 10/12/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2018 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/16/2018 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: CONTINENCE | ||||||
| 12/20/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), TESTOPEL, AVEED | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 12/15/2017 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: CONTINENCE | ||||||
| 12/13/2017 | Akrimax Pharmaceuticals, LLC | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Erectile Dysfunction | ||||||
| 12/06/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Endocrinology | ||||||
| 11/29/2017 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $40.88 | General |
| Category: UROLOGY | ||||||
| 11/06/2017 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 10/25/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), TESTOPEL, AVEED | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 10/04/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi, Vesicare | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Urology | ||||||
| 09/27/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Endocrinology | ||||||
| 09/14/2017 | Rochester Medical Corporation | BMD-Magic3 Catheter (Device) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: Urology | ||||||
| 08/03/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Urology | ||||||
| 08/03/2017 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Prostate Cancer | ||||||
| 07/27/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Oncology | ||||||
| 07/05/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), TESTOPEL, AVEED | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 06/07/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,849 | 2,780 | $968,213 | $131,715 |
| 2022 | 11 | 1,740 | 2,594 | $803,776 | $117,975 |
| 2021 | 11 | 1,635 | 2,257 | $706,389 | $106,332 |
| 2020 | 19 | 2,175 | 2,933 | $1.1M | $142,006 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 362 | 698 | $342,020 | $62,040 | 18.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 86 | 112 | $191,520 | $19,981 | 10.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 207 | $68,310 | $13,064 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $69,840 | $10,629 | 15.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 152 | $55,110 | $8,930 | 16.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 45 | $25,666 | $4,361 | 17.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 323 | 489 | $66,015 | $3,653 | 5.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 188 | 266 | $46,550 | $2,544 | 5.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $14,500 | $2,133 | 14.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 16 | $38,442 | $1,746 | 4.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 326 | 534 | $16,020 | $1,170 | 7.3% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 11 | 11 | $30,140 | $1,000 | 3.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 115 | 136 | $4,080 | $463.76 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 609 | $283,185 | $53,667 | 19.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 91 | 100 | $164,000 | $18,246 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 258 | $80,754 | $15,425 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $72,135 | $12,039 | 16.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 121 | $42,955 | $6,478 | 15.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 321 | 484 | $64,856 | $3,408 | 5.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $17,535 | $3,096 | 17.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 202 | 277 | $50,691 | $2,502 | 4.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $9,605 | $1,713 | 17.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 337 | 549 | $16,470 | $1,216 | 7.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 51 | 53 | $1,590 | $183.49 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 366 | 586 | $254,910 | $53,602 | 21.0% |
About Dr. John Matteucci, M.D
Dr. John Matteucci, M.D is a Urology healthcare provider based in Kenosha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558456749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Matteucci, M.D has received a total of $780.49 in payments from pharmaceutical and medical device companies, with $67.30 received in 2022. These payments were reported across 40 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($682.60).
As a Medicare-enrolled provider, Matteucci has provided services to 7,399 Medicare beneficiaries, totaling 10,564 services with total Medicare billing of $498,029. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Kenosha, WI
- Active Since 10/04/2006
- Last Updated 04/15/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1558456749
Products in Payments
- Xtandi (Drug) $176.64
- Myrbetriq (Drug) $105.78
- GENERAL KIDNEY STONE DISEASE (Device) $79.06
- XIAFLEX (Biological) $67.55
- FIRMAGON (Drug) $54.13
- LUPRON DEPOT (Drug) $54.00
- XTANDI (Drug) $43.89
- SPEEDICATH (Device) $41.18
- BMD-Magic3 Catheter (Device) $40.88
- Androgel (Drug) $27.68
- CONTINENCE CARE (Device) $25.54
- INTERSTIM (Device) $13.86
- LithoVue (Device) $13.30
- ELIGARD (Drug) $12.85
- Stendra (Drug) $12.58
- Uribel (Drug) $11.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.